A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
PHASE3CompletedINTERVENTIONAL
Enrollment
786
Participants
Timeline
Start Date
April 30, 2001
Study Completion Date
December 31, 2002
Conditions
MigraineCommon MigraineClassic MigraineHeadache
Interventions
DRUG
topiramate, propranolol
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00236561 - A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine | Biotech Hunter | Biotech Hunter